Overview

The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study

Status:
Terminated
Trial end date:
2013-05-31
Target enrollment:
Participant gender:
Summary
This blinded, controlled study will examine the impact of pomegranate polyphenol extract (POMx, from Pom Wonderful, LLC), 1000mg on cardiomyopathy in subjects with chronic renal insufficiency.
Phase:
Phase 2
Details
Lead Sponsor:
Jennifer Cowger , MD, MS
Collaborator:
POM Wonderful LLC